跳至主要内容
临床试验/NCT05498025
NCT05498025已完成不适用

The Effect of a Charcoal Deactivation Pouch on Opioid Disposal After Cesarean Delivery

Geisinger Clinic1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2023年2月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
1
主要终点
Actual pouch use

研究概览

简要总结

Background: There is scarce literature investigating how patients dispose of unused opioid supplies after their cesarean postoperative pain has faded. The Office of the Surgeon General has identified research on the prevention of opioid use disorder area as well as research on the management of pain as a "Surgeon General Priority" that needs urgent investigation.

Hypothesis: At least 33% of postpartum women discharged home with an opioid prescription and a drug deactivation pouch will use the pouch to dispose of remaining opioids within 30 days of delivery.

Methods: This is a prospective single arm interventional pilot study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Age 18+ at time of enrollment, per ERM
  • •Delivered ≥26.0 weeks, per ERM
  • •Status post low transverse cesarean delivery, per ERM
  • •Physically located on labor & delivery and is postpartum day #1 or #2 at time of enrollment, per ERM
  • •Opioid prescription has been sent (per ERM) or will be sent (per obstetric team).

排除标准

  • •Positive urine toxicology anytime in pregnancy for non-prescription opioids, fentanyl, amphetamines, benzodiazepines, cannabinoids, LSD, or cocaine, per ERM.
  • •Buprenorphine or methadone Rx, per ERM
  • •Patient preferred communication language not English, per ERM
  • •Documented history, per ERM:
  • •Cannabinoid use disorder
  • •Hypnotic use disorder
  • •Opioid use disorder
  • •Stimulant use disorder
  • •Fibromyalgia
  • •Sickle cell anemia
  • •Lumbar disc herniation
  • •Multiple sclerosis
  • •Trigeminal neuralgia
  • •Active cancer
  • •Complex regional pain syndrome
  • •Systemic lupus erythematosus
  • •Rheumatoid arthritis

研究组 & 干预措施

Activated charcoal pouch

Experimental

The patients in this arm will receive an activated charcoal pouch (Deterra Medium Pouch, UPC #: 850006727001, Verde Environmental Technologies, Minnetonka, MN) for disposal of their opioids after their cesarean delivery pain has resolved.

干预措施: Deterra activated charcoal pouch (Other)

结局指标

主要结局

Actual pouch use

时间窗: 30 days

The percentage of women who used the pouch to dispose of opioids in the home 30 days after delivery (%)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael J. Paglia, MD PhD

Principal Investigator

Geisinger Clinic

研究点 (1)

Loading locations...

相似试验